UNITED THERAPEUTICS Corp Stockholders Equity

Quick Answer

UNITED THERAPEUTICS Corp reported Stockholders Equity of $7.10 billion for the year ending 2025.

  • UNITED THERAPEUTICS Corp showed an increase of +10.1% in Stockholders Equity from 2024 to 2025.
  • This data is from UNITED THERAPEUTICS Corp's annual report (Form 10-K), filed with the SEC on February 25, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2012: $1.01 billion | Q3 2012: $1.06 billion | Q1 2013: $1.15 billion | Q2 2013: $1.17 billion | Q3 2013: $1.26 billion | Q1 2014: $1.32 billion | Q2 2014: $1.17 billion | Q3 2014: $1.18 billion | Q1 2015: $1.09 billion | Q2 2015: $1.04 billion | Q3 2015: $1.47 billion | Q1 2016: $1.71 billion | Q2 2016: $1.81 billion | Q3 2016: $1.84 billion | Q1 2017: $2.07 billion | Q2 2017: $1.78 billion | Q3 2017: $2.07 billion | Q1 2018: $2.37 billion | Q2 2018: $2.57 billion | Q3 2018: $2.69 billion | Q1 2019: $2.32 billion | Q2 2019: $2.56 billion | Q3 2019: $2.72 billion | Q1 2020: $2.95 billion | Q2 2020: $3.09 billion | Q3 2020: $3.28 billion | Q1 2021: $3.45 billion | Q2 2021: $3.64 billion | Q3 2021: $3.83 billion | Q1 2022: $4.18 billion | Q2 2022: $4.32 billion | Q3 2022: $4.56 billion | Q1 2023: $5.12 billion | Q2 2023: $5.41 billion | Q3 2023: $5.71 billion | Q1 2024: $5.34 billion | Q2 2024: $5.70 billion | Q3 2024: $6.10 billion | Q1 2025: $6.81 billion | Q2 2025: $7.17 billion | Q3 2025: $6.59 billion.
  • Over the full 14 years of available data (2012 to 2025), UNITED THERAPEUTICS Corp's Stockholders Equity has grown by 554.6%.
  • Historical annual values: Fiscal year 2025: $7.10 billion | Fiscal year 2024: $6.44 billion | Fiscal year 2023: $5.98 billion | Fiscal year 2022: $4.80 billion | Fiscal year 2021: $3.96 billion | Fiscal year 2020: $3.40 billion | Fiscal year 2019: $2.78 billion | Fiscal year 2018: $2.79 billion | Fiscal year 2017: $2.10 billion | Fiscal year 2016: $1.85 billion | Fiscal year 2015: $1.59 billion | Fiscal year 2014: $1.24 billion | Fiscal year 2013: $1.26 billion | Fiscal year 2012: $1.08 billion.
  • Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: